Contact O'Dwyer's: 271 Madison Ave., #600, New York, NY 10016; Tel: 212/679-2471; Fax: 212/683-2750
O'Dwyer's Inside News of Public Relations & Marketing Communications - odwyerpr.com O'Dwyer's Inside News of Public Relations & Marketing Communications - odwyerpr.com Subscribe to Jack O'Dwyer's Newsletter & get FREE online access plus O'Dwyer's monthly magazin
 
 

O'Dwyer's Newsletter - Oct. 22, 2012 - Vol. 45 - No. 42 (download PDF version)


Page 4 Pages 1, 2, 3, 5, 6, 7, 8
 
MEDIA NEWS continued _____________
 

AILES HIRES NEWSWEEK'S BOYER

Fox News chief Roger Ailes, who has signed a new four-year contract, has recruited senior Newsweek correspondent Peter Boyer for the editor-at-large post at the New Corp. property. Boyer will report to Michael Clemente, executive VP of news editorial, and John Moody, executive editor.

Ailes called Boyer a "talented and insightful journalist who will add added weight and depth to our investigative reporting."

Boyer was staff writer for 18 years at the New Yorker before joining Newsweek. He also was national correspondent at the Los Angeles Times, media reporter at the New York Times, contributing editor to Vanity Fair and a TV critic for NPR's "Morning Edition."

For the New Yorker in 2011, Boyer write a favorable profile of the Putnam County News & Reporter, the upstate paper owned by Ailes and published by his wife, Elizabeth.

MULTIVITAMIN MAKERS LEVERAGE BIG STUDY

Multivitamin makers are cheering a 13-year study published in the Journal of the American Medical Association, which found men who took Pfizer’s Centrum showed a reduced cancer risk of eight percent.

“This study suggests, at least for men, that there might be benefits to taking multivitamins in terms of cancer as well,” said John Michael Gaziano, M.D., chief of the division of aging at Brigham and Women’s Hospital and a researcher at VA Boston who headed the study, which is drawing significant media interest.

Pfizer Consumer Healthcare and agency Ketchum are jumping on the study, which used its Centrum Silver multivitamin.

The PR victory for Pfizer came just months after the company removed claims related to breast and colon health on advertising and labels for Centrum products, after pressure by the Center for Science in the Public Interest.

The new study, published Oct. 17 in the Journal of the American Medical Association, saw researchers track 14,641 men, all doctors, from 1997-2011, finding “daily multivitamin supplementation modestly but significantly reduced the risk of total cancer.”

“We’re very encouraged about the positive news coming out of the Physicians Health Study about multivitamins and we’re honored that Centrum multivitamin was the one chose to be part of the study,” said Rowena Pullan, VP for Pfizer Consumer Healthcare.

The study was conducted by researchers at the Brigham and Women's Hospital and Harvard Medical School.

The Council for Responsible Nutrition, the trade group for dietary supplement makers, said the study is a key endorsement for its members’ products. Duffy MacKay, VP of scientific and regulatory affairs, added that the study “pushes the door and the windows wide open to the benefits and safety of multivitamins.”

The findings were presented last week at the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research in Anaheim.

ARMSTRONG EXITS CHARITY DROPPED BY NIKE

Lance Armstrong is stepping down as head of Livestrong, the cancer patient support juggernaut he founded in 1997 that became one of the world’s most recognizable charity brands.

“I have had the great honor of serving as this foundation’s chairman for the last five years and its mission and success are my top priorities,” he said in a statement Oct. 17.

“Today therefore, to spare the foundation any negative effects as a result of controversy surrounding my cycling career, I will conclude my chairmanship.”

Armstrong, who started the organization after a bout with testicular cancer, last month pulled the plug on his years-long legal and PR fight against doping charges as the World Anti-Doping Agency closed in on the seven-time Tour de France winner. The organization last week released a report containing significant evidence and testimony from teammates that Armstrong led a doping scheme for his racing teams.

His resignation from the charity sparked one of his biggest corporate backers, Nike, to end its longstanding relationship with the cyclist.

“Due to the seemingly insurmountable evidence that Lance Armstrong participated in doping and misled Nike for more than a decade, it is with great sadness that we have terminated our contract with him,” the athletic apparel company said in a statement, adding it will continue to support the Livestrong charity.

Vice chairman Jeff Garvey, an Austin venture capital titan, takes the reins of Livestrong on Armstrong’s exit. Livestrong has raised nearly $500M over the past 15 years, including from the sale of its iconic yellow bracelets.

BROOKS BAGS $11M

Rebekah Brooks, former CEO of News International and a central figure in its hacking scandal, received $11M in severance pay following her resignation last year, according to British media reports.

The former editor of the now shuttered News of the World goes on trial next year.

The Guardian reported that Brooks’ contract includes “clawback” provisions that give NI the right to recover some of her severance if she is “found guilty of a criminal offense relating to her employment.” She has been charged with concealing evidence from investigators. Brooks also edited The Sun.

BRIEF: Henrique de Castro, who is in charge of Google’s ad platforms and services, will join Yahoo as president & COO early next year. CEO Marissa Mayer, a Google alum, said de Castro's operational experience and “proven success in structuring and scaling global organizations” makes his a perfect fit for the struggling company.

 
Page 4 Pages 1, 2, 3, 5, 6, 7, 8

 
Copyright © 1998-2020 J.R. O'Dwyer Company, Inc.
271 Madison Ave., #600, New York, NY 10016; Tel: 212/679-2471